Skip to content

Comparison of oxygen exposure amount between ORI and control groups in thoracic surgery

Comparison of oxygen exposure amount between oxygen reserve index based FIO2 titration and conventional FIO2 titration in thoracic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004782
Enrollment
158
Registered
2020-03-03
Start date
2021-03-21
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Test group: In addition to the routine anesthesia monitor device, ORI monitor [Multiwave pulse co-oximetry (Radical-7
Masimo, Irvine, CA)] is attached to the subject's finger during surgery to observe the degree of oxygen reserve. This device is a non-invasive device that measures the oxygen saturation of capillaries

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Regular Pneumonectomy under General Anesthesia (2) one hour or more of one lung ventilation (3) ASA class 1-3 patients (4) Adults who can write a consent form (19 years old or older)

Exclusion criteria

Exclusion criteria: (1) ASA physical status ? or higher: ex) Patients requiring immediate medical treatment due to severe systemic diseases (2) Heart failure (hypertension, oliguria, pulmonary edema, left ventricular ejection fraction <45%) and preoperative inotropes (3) Artificial ventilation and oxygen therapy immediately before surgery (4) large emphysema and pneumothorax (5) pregnancy and lactation (6) patients participating in similar studies (7) other surgery and joint operation (8) Patients who do not understand the study or have indicated their intention not to participate in the study. (9) patients with elevated blood pressure (10) patients with peripheral neuropathy or blood circulation disorders (11) patients with hemoglobin disease (12) congenital heart disease with cardiac shunt

Design outcomes

Primary

MeasureTime frame
oxygne exposure amount

Secondary

MeasureTime frame
Incidence of PaO2 >250 mmHg;incidence of arterial oxgyen saturaiton <94% and <90%;PaO2/FIO2;Incidence of postoperative complications

Countries

Korea, Republic of

Contacts

Public ContactHyun Joo Ahn

Samsung Medical Center

hyunjooahn@skku.edu+82-2-3410-0784

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026